MLKL Confers Ferroptosis Resistance in Colorectal Cancer Cells via Impaired ESCRT-III-Mediated Membrane Repair

Researchers identified mixed lineage kinase domain-like protein (MLKL) as a key regulator of ferroptosis resistance in colorectal cancer, promoting tumor cell survival by coordinating antioxidant defenses and ESCRT-III–mediated membrane repair.